Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited (TLX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TLX · as of Jun 8, 2026
Key Statistics
Explore Telix Pharmaceuticals Limited Data
tlx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The TLX analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +84.38% upside from the current price of $9.22.
Competitors & Peers
tlx competitorsTLX
ACAD
ADMA
BLTE
CELC
DYNStock Performance
Full HistoryAbout Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited (TLX) is a commercial-stage biopharmaceutical entity specializing in the creation and distribution of advanced radiopharmaceuticals. Its core mission is to develop both d…
what is telix pharmaceuticals limited · tlx stock overview · telix pharmaceuticals limited company profile · who is telix pharmaceuticals limited ceo · tlx NASDAQ · telix pharmaceuticals limited headquarters · telix pharmaceuticals limited business segments
About Stock Overview & Key Data
Telix Pharmaceuticals Limited (TLX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 14, 2024. As of the latest trading session, TLX stock price is $9.22, with a market capitalization of $3.1B. The stock has returned -44.94% over the past 12 months and +24.30% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Telix Pharmaceuticals Limited stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Telix Pharmaceuticals Limited reported revenue of $1.2B and net income of -$10.7M. For detailed data — including Telix Pharmaceuticals Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Telix Pharmaceuticals Limited (TLX) stock price is $9.22. The stock is traded on NASDAQ under the ticker symbol TLX. The 52-week range is $6.28 – $18.49.